UNSPSC 51473002: Benzoxonium chloride

This classification denotes an anti-infective agent with the molecular formula C23H42NO2.Cl, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 12IMO9R11X, chemically known as n-dodecyl-n,n-bis(2-hydroxyethyl)benzenemethanaminium chloride but generally known as benzoxonium chloride, which bears US NIH Compound Identifier 29563. European Medicines Agency schedules Benzoxonium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05764MIG.

UNSPSC 51473002 Benzoxonium chloride is a Commodity code that covers quaternary ammonium disinfectant compounds used in janitorial and healthcare settings. State and local governments procure benzoxonium chloride as part of broader consumable supplies for fire departments, public facilities, and healthcare institutions that require EPA-approved antimicrobial agents for surface disinfection and sanitation. The issuing bodies under this code span county government purchasing offices and state cooperative-purchasing alliances that aggregate demand across multiple jurisdictions and member agencies. Solicitations typically bundle benzoxonium chloride with other janitorial, cleaning, and pharmaceutical supplies rather than procuring it as a standalone item, reflecting the operational structure of state and local supply chains where disinfectant compounds are ordered alongside detergents, paper products, and personal protective equipment.

The code shows recent activity centered in Florida and the Upper Midwest through multi-state cooperative purchasing vehicles. Hillsborough County Board of County Commissioners (Tampa, Florida) issued ITB2600319 on July 7, 2026, for janitorial and operational supplies to support 47 fire stations operating around the clock, with an estimated one-year contract value of $765,679.84 and bids due July 24, 2026 at 2:00 p.m. Eastern Time. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted RFP S1070000015802 on January 20, 2026, to establish multi-source pharmaceutical and OTC product contracts across participating state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026. Both solicitations require authorized-distributor status and compliance with supply-chain security and manufacturing-practice certifications. The MMCAP procurement structure emphasizes price competitiveness (75 percent of evaluation weight) and mandates participation through three designated wholesalers with chargeback systems in place.